LARP1 and ovarian cancer: Interestingly, this finding was not limited to ovarian cancer; by analysing overall survival in 1115 breast cancer patients, we found that high LARP1 expression was also predictive of poor outcome (HR = 1.53, P < 0.001, 95% CI 1.2–1.96; Supplementary Figure S7G), suggesting an oncogenic role for LARP1 in other tumour types.